Potential therapeutic targets of triple-negative breast cancer based on its intrinsic subtype

Triple-negative breast cancer (TNBC) is an aggressive subgroup of human breast cancer, which is characterized as estrogen receptor (ER) negative, progesterone receptor (PR) negative, and human epidermal growth factor receptor 2 (HER2) negative. TNBC is the most difficult breast cancer subgroup to tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Fangyuan, Sun, Heng, Deng, Chu-Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641215/
https://www.ncbi.nlm.nih.gov/pubmed/29069872
http://dx.doi.org/10.18632/oncotarget.20274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641215/
https://www.ncbi.nlm.nih.gov/pubmed/29069872
http://dx.doi.org/10.18632/oncotarget.20274

Ejemplares similares